Patent · US Active

HLA-restricted VCX/Y peptides and T cell receptors and use thereof

US11696933B2 · kind B2 · utility

0Cited by

1References

34Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Cassian YEE · Seattle, US
Ke PAN · Chadds Ford, US

Key dates

Filing date	Dec 28, 2017
Grant date	Jul 11, 2023
Priority date	—
Expiry date	Jul 18, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are tumor-antigen VCX/Y specific peptides and engineered VCX/Y specific T cell receptors. Also provided herein are methods of generating VCX/Y-specific immune cells and their use for the treatment of cancer. In addition, the VCX/Y-specific peptides may be used as a vaccine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.